Cardlytics Future Growth
Future criteria checks 0/6
Cardlytics is forecast to grow earnings and revenue by 81% and 2.2% per annum respectively while EPS is expected to grow by 64.6% per annum.
Key information
81.0%
Earnings growth rate
64.6%
EPS growth rate
| Media earnings growth | 14.0% |
| Revenue growth rate | 2.2% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 10 Dec 2024 |
Recent future growth updates
Recent updates
Cardlytics Continues Revenue Contraction Amid Worsening Economics
Dec 07Estimating The Intrinsic Value Of Cardlytics, Inc. (NASDAQ:CDLX)
Nov 23
After Leaping 27% Cardlytics, Inc. (NASDAQ:CDLX) Shares Are Not Flying Under The Radar
Nov 05Is Cardlytics (NASDAQ:CDLX) Using Too Much Debt?
Oct 15Cardlytics: Execution Risks Are Elevated, But Reasons For Optimism Remain (Maintain Hold Rating)
Sep 17Cardlytics, Inc.'s (NASDAQ:CDLX) 63% Share Price Plunge Could Signal Some Risk
Aug 09Cardlytics: Has Multiple Potential Growth Levers, But Persistent Risks Remain
Jul 02Cardlytics, Inc.'s (NASDAQ:CDLX) Stock Retreats 30% But Revenues Haven't Escaped The Attention Of Investors
May 31The Power Of Cardlytics' Data Partnerships Including Bank of America
Apr 17Cardlytics, Inc.'s (NASDAQ:CDLX) 81% Jump Shows Its Popularity With Investors
Apr 10Cardlytics: Good Prospects But Macro Uncertain
Feb 16Cardlytics, Inc.'s (NASDAQ:CDLX) 29% Share Price Plunge Could Signal Some Risk
Jan 18Would Cardlytics (NASDAQ:CDLX) Be Better Off With Less Debt?
Jan 04We Think Cardlytics (NASDAQ:CDLX) Has A Fair Chunk Of Debt
Oct 05Does Cardlytics (NASDAQ:CDLX) Have A Healthy Balance Sheet?
Jun 18Cardlytics, Inc. (NASDAQ:CDLX) Stock Rockets 105% But Many Are Still Ignoring The Company
Apr 17Is Cardlytics, Inc. (NASDAQ:CDLX) Trading At A 38% Discount?
Mar 03Is Cardlytics (NASDAQ:CDLX) A Risky Investment?
Jan 10Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 294 | N/A | N/A | 7 | 1 |
| 12/31/2025 | 277 | -76 | 3 | 3 | 6 |
| 12/31/2024 | 268 | -198 | -166 | -148 | 6 |
| 9/30/2024 | 293 | -275 | -27 | -9 | N/A |
| 6/30/2024 | 305 | -153 | -26 | -9 | N/A |
| 3/31/2024 | 312 | -173 | -22 | -8 | N/A |
| 12/31/2023 | 309 | -135 | -13 | 0 | N/A |
| 9/30/2023 | 303 | -412 | -28 | -16 | N/A |
| 6/30/2023 | 296 | -382 | -44 | -32 | N/A |
| 3/31/2023 | 295 | -485 | -58 | -44 | N/A |
| 12/31/2022 | 299 | -465 | -67 | -54 | N/A |
| 9/30/2022 | 306 | -99 | -55 | -41 | N/A |
| 6/30/2022 | 298 | -150 | -51 | -37 | N/A |
| 3/31/2022 | 282 | -71 | -58 | -46 | N/A |
| 12/31/2021 | 267 | -129 | -51 | -39 | N/A |
| 9/30/2021 | 244 | -124 | -45 | -32 | N/A |
| 6/30/2021 | 225 | -94 | -40 | -27 | N/A |
| 3/31/2021 | 195 | -67 | -29 | -17 | N/A |
| 12/31/2020 | 187 | -55 | -18 | -8 | N/A |
| 9/30/2020 | 189 | -45 | -20 | -9 | N/A |
| 6/30/2020 | 199 | -38 | -2 | 7 | N/A |
| 3/31/2020 | 220 | -24 | -1 | 10 | N/A |
| 12/31/2019 | 210 | -17 | 0 | 11 | N/A |
| 9/30/2019 | 189 | -32 | -7 | 3 | N/A |
| 6/30/2019 | 167 | -33 | -20 | -9 | N/A |
| 3/31/2019 | 154 | -39 | -29 | -20 | N/A |
| 12/31/2018 | 151 | -53 | -26 | -19 | N/A |
| 9/30/2018 | 142 | -46 | -25 | -20 | N/A |
| 6/30/2018 | 139 | -41 | N/A | -29 | N/A |
| 3/31/2018 | 136 | -33 | N/A | -16 | N/A |
| 12/31/2017 | 130 | -25 | N/A | -22 | N/A |
| 9/30/2017 | 128 | -28 | N/A | -19 | N/A |
| 6/30/2017 | 127 | -51 | N/A | -16 | N/A |
| 3/31/2017 | 120 | -77 | N/A | -26 | N/A |
| 12/31/2016 | 113 | -77 | N/A | -32 | N/A |
| 12/31/2015 | 78 | -42 | N/A | -29 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CDLX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CDLX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CDLX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CDLX's revenue (2.2% per year) is forecast to grow slower than the US market (9.2% per year).
High Growth Revenue: CDLX's revenue (2.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CDLX's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 00:14 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cardlytics, Inc. is covered by 14 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nathaniel Schindler | BofA Global Research |
| Omar Dessouky | BofA Global Research |
| Jason Kreyer | Craig-Hallum Capital Group LLC |